Literature DB >> 2172627

External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph.

L T Jensen1, H P Olesen, J Risteli, I Lorenzen.   

Abstract

An experimental animal model for lymph studies is described. Thoracic duct-venous shunt was established in 12 pigs. Shunt patency averaged 5.5 days. The composition of connective tissue metabolites in lymph and serum were investigated during a standardized surgical operation (thoracotomy) under general anesthesia. We measured the carboxyterminal propeptide of type I procollagen (PICP), the aminoterminal propeptide of type III procollagen (PIIINP) hyaluronan (HA) and total protein. During surgery/anesthesia lymph PICP (p less than 0.04), lymph PIIINP (p less than 0.03) and serum PIIINP (p less than 0.01) and serum PIIINP (p less than 0.03) increased. The changes may be explained by the inactive physical state of the animals. HA showed wide variations, with a tendency like PIIINP. In conscious animals the lymph/serum ratio of PIIINP and HA were 10 and 35, respectively, indicating that lymph is a major route of tissue clearance for these components. The lymph/serum ratio of PICP was 1.0 in conscious pigs, indicating a direct release into the circulation. Total protein in lymph decreased (p less than 0.04) during surgery/anesthesia, whereas no changes were observed in serum. Pigs can be used instead of dogs and sheep in studies on lymph. The effect of surgery/anesthesia must be taken into consideration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172627

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  8 in total

Review 1.  Use of a marker of collagen formation in osteoporosis studies.

Authors:  J Risteli; J Melkko; S Niemi; L Risteli
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

2.  Biochemical bone markers compared with bone density measurement by dual energy X-ray absorptiometry.

Authors:  J Lotz; D Steeger; G Hafner; W Ehrenthal; J Heine; W Prellwitz
Journal:  Calcif Tissue Int       Date:  1995-10       Impact factor: 4.333

3.  Increased degradation of type I collagen in patients with inflammatory bowel disease.

Authors:  J Silvennoinen; L Risteli; T Karttunen; J Risteli
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

4.  Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.

Authors:  P Charles; C Hasling; L Risteli; J Risteli; L Mosekilde; E F Eriksen
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333

5.  Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.

Authors:  J Kjeldsen; O B Schaffalitzky de Muckadell; P Junker
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

6.  Techniques for thoracic duct cannulation without thoracotomy in piglets.

Authors:  Hung-Hsun Yen; Helen M S Davies
Journal:  BMC Vet Res       Date:  2016-09-15       Impact factor: 2.741

Review 7.  Intestinal lymphatic transport for drug delivery.

Authors:  Jaime A Yáñez; Stephen W J Wang; Ian W Knemeyer; Mark A Wirth; Kevin B Alton
Journal:  Adv Drug Deliv Rev       Date:  2011-06-13       Impact factor: 15.470

8.  Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells.

Authors:  J Melkko; T Hellevik; L Risteli; J Risteli; B Smedsrød
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.